CEVA vs JAZZ · P/E 244, rev $29.0M vs P/E 1988, rev $2.28B
CEVA Inc (CEVA) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
CEVA Inc (CEVA) is a semiconductors company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported CEVA revenue for 2026-06-30 was $29.0M. Net income was -$2.9M. Revenue was up 7.4% from 2026-03-31 to 2026-06-30. CEVA currently screens at market cap $525.7M and trailing P/E 244.2.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CEVA currently screens at market cap $525.7M and trailing P/E 244.2. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CEVA and JAZZ stock pages for the full models.
Not investment advice.